PagrindinisMDTC34 • BVMF
add
Medtronic
Ankstesnė uždarymo kaina
256,40 R$
Metų intervalas
197,93 R$ - 261,74 R$
Bendroji vertė rinkoje
110,94 mlrd. USD
Vidutinė prekybos apimtis
50,00
Aktualios naujienos
Finansiniai rodikliai
Pajamų ataskaita
Pajamos
Grynosios pajamos
(USD) | 2024-10info | Metinis pokytis |
---|---|---|
Pajamos | 8,40 mlrd. | 5,25 % |
Veiklos sąnaudos | 3,78 mlrd. | 2,30 % |
Grynosios pajamos | 1,27 mlrd. | 39,71 % |
Grynojo pelno marža | 15,11 | 32,66 % |
Pelnas tenkantis vienai akcijai | 1,26 | 0,80 % |
EBITDA | 2,36 mlrd. | 6,70 % |
Taikomas mokesčio tarifas | 18,01 % | — |
Balansas
Visas turtas
Visi įsipareigojimai
(USD) | 2024-10info | Metinis pokytis |
---|---|---|
Lėšos, trump. investicijos | 7,99 mlrd. | 3,30 % |
Visas turtas | 90,04 mlrd. | −0,05 % |
Visi įsipareigojimai | 41,33 mlrd. | 7,51 % |
Visos paprastosios akcijos | 48,72 mlrd. | — |
Išleistos akcijos | 1,28 mlrd. | — |
Kaina / apskaitinė vertė | 6,78 | — |
Turto grąža | 4,68 % | — |
Kapitalo grąža | 5,50 % | — |
Pinigų srautas
Grynasis pokytis (grynaisiais pinigais)
(USD) | 2024-10info | Metinis pokytis |
---|---|---|
Grynosios pajamos | 1,27 mlrd. | 39,71 % |
Pinigai iš operacijų | 958,00 mln. | 44,93 % |
Pinigai iš investicijų | −345,00 mln. | 18,63 % |
Pinigai iš finansavimo | −534,00 mln. | −493,33 % |
Grynasis pokytis (grynaisiais pinigais) | 83,00 mln. | 396,43 % |
Laisvas pinigų srautas | 748,25 mln. | 16,23 % |
Apie
Medtronic plc is an American-Irish medical device company. The company's operational and executive headquarters are in Minneapolis, Minnesota, and its legal headquarters are in Ireland due to its acquisition of Irish-based Covidien in 2015. While it primarily operates in the United States, it operates in more than 150 countries and employs over 90,000 people. It develops and manufactures healthcare technologies and therapies. It is one of the biggest medical tech companies in the world and is currently the largest medical device company in the world by revenue.
Medtronic's pioneering innovations have transformed healthcare through ground-breaking medical devices. The company has developed several world-first technologies since its inception, including wearable and implantable pacemakers, the implantable cardioverter defibrillator, and remote monitoring systems. They also created breakthrough solutions in diabetes care with the first 24-hour automated insulin delivery, deep brain stimulation, and miniaturized devices like the world's smallest pacemaker and spinal cord stimulator. Wikipedia
Generalinis direktorius
Įkurta
1949
Svetainė
Darbuotojų skaičius
95 000